With the anticipated passing of the PRC Futures and Derivatives Law in 2022, now is the time for Chinese financial institutions and their counterparties to actively focus on regulatory margin requirements for OTC derivatives and related legal documentation issues.
Based on KWM’s extensive experience in advising major international and Chinese financial institutions and corporates on these issues, below are our answers to some frequently asked questions on this important topic.
Key Contacts
- Hong Kong SAR: Minny Siu and Andrew Fei
- China Mainland: Stanley Zhou and David Mu


Download
8.80MB, 9 Pages